Analýza fenotypu a kinetiky subpopulací CD34+ bunĕk a lymfocytů dárců periferních hematopoetických kmenových bunĕk pro alogenní transplantace
[Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article
PubMed
14515444
- MeSH
- Antigens, CD34 analysis MeSH
- Tissue Donors * MeSH
- Granulocyte Colony-Stimulating Factor pharmacology MeSH
- Filgrastim MeSH
- Immunophenotyping * MeSH
- Humans MeSH
- Hematopoietic Stem Cell Mobilization MeSH
- Lymphocyte Subsets * MeSH
- Recombinant Proteins MeSH
- Hematopoietic Stem Cell Transplantation * MeSH
- Check Tag
- Humans MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Names of Substances
- Antigens, CD34 MeSH
- Granulocyte Colony-Stimulating Factor MeSH
- Filgrastim MeSH
- Recombinant Proteins MeSH
BACKGROUND: Amount of CD34+ cells is a critical parameter for quality assessment and successful engraftment of peripheral blood hematopoietic stem cells (PBSC) during the transplantation of haemopoisis. CD34+ cells are routinely analysed by immunophenotyping in PBSC and in peripheral blood during mobilization. Other leukocyte subpopulations are not usually assessed. METHODS AND RESULTS: The authors present results of immunophenotyping of subpopulations of CD34+ cells and leucocytes in samples from donors of PBSC for allogeneic transplantations, who were stimulated with the growth factor G-CSF at dose 16 micrograms/kg/day. The amount of CD34+ cells was not significantly different between days 4 and 5; however, there was a significant drop at day 6. CD34+90+ and CD34+61+ subpopulations reached their maximum at the day 4; partially differentiated CD34+ cells with co-expression of CD33, CD19, and CD7 reached maximum at the day 6. CD4+ Th-lymphocytes were concentrated in the grafts during leukapheresis, CD4/CD8 ratio in the grafts was increased to average 3.06. CONCLUSIONS: The knowledge of kinetics of CD34+ subpopulations, together with stem cell selection and ex vivo manipulation, may have an impact on the speed of engraftment or GvHD prevention in transplanted patients.